Catherine Deacon Email and Phone Number
Catherine is a financial executive in the global biopharmaceutical industry with over 20 years of leadership in research and development finance and business development currently responsible for financial leadership of the 4 therapeutic areas of Takeda: Oncology, Neuroscience, Gastro Intestinal, and Rare Diseases.Catherine joined Takeda in 2017 and her current role is Senior Director of Finance, Therapeutic Asset Units, Research and Development with financial and strategic leadership for 4 Therapeutic Asset Portfolios: Oncology, Neuroscience, Gastrointestinal and Rare Disease encompassing all PH I-IV development assets, portfolio development , and external partnerships. Prior to Takeda, she was with EMD Serono from 2013 - 2017 as Head of Controlling US for Global Research and Development with responsibility for early and late stage R&D programs and external collaborations. Prior to EMD Catherine was with Pfizer for 10 years, in finance leadership roles in R&D, including financial planning, budgeting, analysis, and the lead for an integration, and for the Center for Integrative Biologics and Biolomics Research Unit, and for the Inflammation and Remodeling Research Unit . Prior to Pfizer, Catherine was the Chief financial officer for a medical start-up focused, and served as Controller, Director of Finance, Domestic and International, and Finance lead for the Marketing Division for Pitney Bowes.External activities include Board of Director roles for the Center for the Arts, and a life long history of volunteering and activism for community health, education and the underserved populations.
-
Senior Director, Research And Development Finance, Therapeutic Area UnitsTakeda Sep 2021 - PresentTokyo, JpFinancial Leadership and strategic planning for the 4 therapeutic asset areas within Takeda: Oncology, Neuroscience, Gastrointestinal and Rare Diseases. Responsible for budgeting, planning, evaluations, NPV analysis, prioritization, decision making on programs, and long range forecast for all asset programs PH I-IV. Manage external partnerships, co development of assets with multiple global partners. Preparation and presentation to R&D leadership for investments into potential asset development.
-
Senior Director, Portfolio Strategy And Finance OperationsTakeda Pharmaceuticals International, Inc. Mar 2017 - Sep 2021Financial and strategic leadership for Financial Planning & Analysis for Global R&D . Member of the R&D Steering Committee, and the Executive Committee for External Partnerships, and Diversity and Inclusion lead. Manage a direct international staff of 16 to include North America, Europe and Asia,Indirect staff: 3000 Budget : 2 Billion; 1B in external investmentsFinancial and strategic leadership for the Worldwide Asset enabling functions to include:Global Regulatory AffairsGlobal Patient and Safety EvaluationGlobal Medical AffairsGlobal Clinical OperationsMarketed Products R&DGlobal Data ScienceGlobal Quality Assurance -
Director, R&D Controlling, Worldwide Development ProgramsEmd Serono, Inc. Jan 2015 - Mar 2017Boston, Massachusetts, UsStrengths: Finance Leadership, financial planning and analysis, reporting, internal controls, governance processes, operating plan development, business partnering and collaboration with scientific leads, cross functional collaboration, change management, providing direction and clarity in a matrix environment, process improvement. Worldwide responsibility for late stage research and development programs; ( PHI through PH IV), external collaborations. Portfolio evaluation and prioritization, operating plan, strategic planning, budgeting, forecasting over multi year horizon for worldwide programs. Lead multiple cross functional initiatives. Represent EMD to top three external collaborations, including premier partnership in the history of Pharma. Accomplishments include design and lead operating plan process, development and implementation of a new R&D project demand planning and forecasting model, cross team coordination and implementation of planisware, build a US team to support growth in domestic market. Budget; $1B; staff: US 5 Europe 3 -
Senior Controller, Research And DevelopmentEmd Serono, Inc. Jul 2013 - Jan 2015Boston, Massachusetts, Us
-
Associate Director, Finance, Biotherapeutics ResearchPfizer Jan 2010 - Jul 2013New York, New York, Us -
Manager,Finance, Oncology Business UnitPfizer Jan 2009 - Jan 2010New York, New York, Us
-
Senior Portfolio Liaison, Finance And TechnologyPfizer Jan 2008 - Jan 2009New York, New York, Us
-
Chief Financial OfficerCww Jan 2006 - Jan 2007
-
ControllerPitney Bowes Jul 1989 - Dec 2004Stamford, Ct, Us
Catherine Deacon Education Details
-
University Of ConnecticutFinance -
Temple University School Of PharmacyQuality Affairs/Regulatory Assurance
-
University Of ConnecticutFinance
Frequently Asked Questions about Catherine Deacon
What company does Catherine Deacon work for?
Catherine Deacon works for Takeda
What is Catherine Deacon's role at the current company?
Catherine Deacon's current role is Senior Director, Research and Development Finance,Takeda Pharmaceuticals International.
What schools did Catherine Deacon attend?
Catherine Deacon attended University Of Connecticut, Temple University School Of Pharmacy, University Of Connecticut.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial